Investor Sues Drug Maker, Others Over Alleged IPO Misstatements
LOS ANGELES — A shareholder filed a securities class action complaint in California state court on Dec. 1, alleging that a clinical-stage biopharmaceutical company and certain of its executive officers misrepresented...To view the full article, register now.
Already a subscriber? Click here to view full article